Simplex Trading, LLC Infla Rx N.V. Transaction History

Simplex Trading, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$1.18 - $1.74 $174 - $257	148 Added 49.17%	449 $0
Q1 2024 Apr 25, 2024	SELL	$1.47 - $2.03 $1,866 - $2,578	-1,270 Reduced 80.84%	301 $0
Q4 2023 Feb 02, 2024	SELL	$1.25 - $2.75 $7,388 - $16,255	-5,911 Reduced 79.0%	1,571 $2,000
Q3 2023 Nov 01, 2023	SELL	$2.66 - $4.33 $46,417 - $75,558	-17,450 Reduced 69.99%	7,482 $22,000
Q2 2023 Aug 04, 2023	BUY	$2.05 - $6.1 $26,420 - $78,616	12,888 Added 107.01%	24,932 $111,000
Q1 2023 Apr 27, 2023	SELL	$1.66 - $3.1 $27,964 - $52,222	-16,846 Reduced 58.31%	12,044 $23,000
Q4 2022 Feb 02, 2023	BUY	$2.11 - $3.25 $47,342 - $72,920	22,437 Added 347.7%	28,890 $89,000
Q3 2022 Nov 04, 2022	BUY	$1.32 - $3.14 $873 - $2,078	662 Added 11.43%	6,453 $17,000
Q2 2022 Aug 03, 2022	BUY	$0.78 - $1.9 $1,517 - $3,695	1,945 Added 50.57%	5,791 $8,000
Q2 2021 Aug 12, 2021	SELL	$2.72 - $4.04 $2,758 - $4,096	-1,014 Reduced 20.86%	3,846 $11,000
Q1 2021 Apr 26, 2021	BUY	$3.62 - $6.34 $445 - $779	123 Added 2.6%	4,860 $18,000
Q4 2020 Feb 02, 2021	BUY	$3.82 - $5.32 $18,095 - $25,200	4,737 New	4,737 $23,000
Q3 2020 Oct 14, 2020	SELL	$3.7 - $5.47 $13,745 - $20,321	-3,715 Closed	0 $0
Q2 2020 Jul 13, 2020	BUY	$4.59 - $8.96 $17,051 - $33,286	3,715 New	3,715 $17,000

12.9M

19.3K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $99M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.